{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T07:42:21Z","timestamp":1792654941279,"version":"4.5.0"},"update-to":[{"DOI":"10.1002\/14651858.cd003427.pub4","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,3,16]],"date-time":"2021-03-16T00:00:00Z","timestamp":1615852800000}}],"reference-count":56,"publisher":"Wiley","issue":"3","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd003427.pub5","type":"journal-article","created":{"date-parts":[[2021,3,16]],"date-time":"2021-03-16T12:34:28Z","timestamp":1615898068000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Prophylactic antibiotics for preventing pneumococcal infection in children with sickle cell disease"],"prefix":"10.1002","volume":"2021","author":[{"given":"Angela E","family":"Rankine-Mullings","sequence":"additional","affiliation":[{"name":"Sickle Cell Unit; Caribbean Institute for Health Research, University of the West Indies; Kingston Jamaica"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirley","family":"Owusu-Ofori","sequence":"additional","affiliation":[{"name":"Transfusion Medicine Unit; Komfo Anokye Teaching Hospital; Kumasi Ghana"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2021,3,16]]},"reference":[{"issue":"6430","key":"10.1002\/14651858.CD003427.pub5-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1136\/bmj.288.6430.1567","article-title":"Prevention of pneumococcal infection in children with homozygous sickle cell disease","volume":"288","author":"John","year":"1984","journal-title":"British Medical Journal (Clinical Research Edition)"},{"issue":"1-2","key":"10.1002\/14651858.CD003427.pub5-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/sim.4780090111","article-title":"Sickle cell anaemia trial","volume":"9","author":"Gaston","year":"1990","journal-title":"Statistics in Medicine"},{"issue":"25","key":"10.1002\/14651858.CD003427.pub5-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1056\/NEJM198606193142501","article-title":"Prophylaxis with oral penicillin in children with sickle cell anemia: a randomized trial","volume":"314","author":"Gaston","year":"1986","journal-title":"New England Journal of Medicine"},{"issue":"5","key":"10.1002\/14651858.CD003427.pub5-BIB0004|cit4","first-page":"1828","article-title":"Use of penicillin prophylaxis in sickle cell disease","volume":"53","year":"1996","journal-title":"American Family Physician"},{"issue":"6","key":"10.1002\/14651858.CD003427.pub5-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/S0022-3476(96)70026-4","article-title":"Serotype-specific immunoglobulin G antibody responses to pneumococcal vaccine in children with sickle cell anemia: effects of continued penicillin prophylaxis","volume":"129","author":"Bjornson","year":"1996","journal-title":"Journal of Pediatrics"},{"issue":"5","key":"10.1002\/14651858.CD003427.pub5-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0022-3476(95)70154-0","article-title":"Discontinuing penicillin prophylaxis in children with sickle cell anemia. Prophylactic Penicillin Study II","volume":"127","author":"Falletta","year":"1995","journal-title":"Journal of Pediatrics"},{"issue":"4","key":"10.1002\/14651858.CD003427.pub5-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/00043426-199707000-00011","article-title":"Influence of penicillin prophylaxis on antimicrobial resistance in nasopharyngeal S. pneumoniae among children with sickle cell anemia. The Ancillary Nasopharyngeal Culture Study of Prophylactic Penicillin Study II","volume":"19","author":"Woods","year":"1997","journal-title":"Journal of Pediatric Hematology\/Oncology"},{"issue":"3","key":"10.1002\/14651858.CD003427.pub5-BIB0008|cit8","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1080\/02724936","article-title":"Prophylaxis of pneumococcal infection in sickle-cell disease by the combined use of vaccination and penicillin","volume":"6","author":"Babiker","year":"1986","journal-title":"Annals of Tropical Paediatrics"},{"issue":"6","key":"10.1002\/14651858.CD003427.pub5-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1046\/j.1365-2125.1998.00730.x","article-title":"Trying to improve compliance with prophylactic penicillin therapy in children with sickle cell disease","volume":"45","author":"Berkovitch","year":"1998","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"5","key":"10.1002\/14651858.CD003427.pub5-BIB0010|cit10","first-page":"196","article-title":"A trial of chemoprophylaxis in sickle cell anaemia. Preliminary communication.","volume":"39","author":"Lewthwaite","year":"1962","journal-title":"East African Medical Journal"},{"issue":"1","key":"10.1002\/14651858.CD003427.pub5-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0022-3476(84)80582-X","article-title":"Effect of penicillin prophylaxis on nasopharyngeal colonization with Streptococcus pneumoniae in children with sickle cell anemia","volume":"104","author":"Anglin","year":"1984","journal-title":"Journal of Pediatrics"},{"issue":"6","key":"10.1002\/14651858.CD003427.pub5-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/S0022-3476(96)70026-4","article-title":"Serotype-specific immunoglobulin G antibody responses to pneumococcal vaccine in children with sickle cell anemia: effects of continued penicillin prophylaxis","volume":"129","author":"Bjornson","year":"1996","journal-title":"Journal of Pediatrics"},{"key":"10.1002\/14651858.CD003427.pub5-BIB0013|cit13","volume-title":"British National Formulary","author":"Joint Formulary Committee","year":"2020"},{"issue":"12","key":"10.1002\/14651858.CD003427.pub5-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1056\/NEJMoa1408544","article-title":"Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults","volume":"372","author":"Bonten","year":"2015","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD003427.pub5-BIB0015|cit15","doi-asserted-by":"publisher","first-page":"g1765","DOI":"10.1136\/bmj.g1765","article-title":"Management of sickle cell disease in the community","volume":"348","author":"Brousse","year":"2014","journal-title":"BMJ"},{"issue":"8","key":"10.1002\/14651858.CD003427.pub5-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"a025247","DOI":"10.1101\/cshperspect.a025247","article-title":"\u03b2-Lactams and \u03b2-Lactamase Inhibitors: An Overview","volume":"6","author":"Bush","year":"2016","journal-title":"Cold Spring Harbour Perspectives in Medicine"},{"issue":"1","key":"10.1002\/14651858.CD003427.pub5-BIB0017|cit17","doi-asserted-by":"publisher","first-page":"e2019042","DOI":"10.4084\/MJHID.2019.042","article-title":"Sickle cell disease and infections in high- and low-income countries","volume":"11","author":"Cannas","year":"2019","journal-title":"Mediterranean Journal of Hematology and Infectious Diseases"},{"key":"10.1002\/14651858.CD003427.pub5-BIB0018|cit18","unstructured":"Centers for Disease Control and Prevention https:\/\/www.cdc.gov\/ncbddd\/sicklecell\/data.html www.cdc.gov\/ncbddd\/sicklecell\/data.html"},{"issue":"8","key":"10.1002\/14651858.CD003427.pub5-BIB0019|cit19","first-page":"912","article-title":"The escalating problem of antimicrobial resistance in Streptococcus pneumoniae","volume":"146","author":"Chesney","year":"1992","journal-title":"American Journal of Diseases of Children"},{"key":"10.1002\/14651858.CD003427.pub5-BIB0020|cit20","doi-asserted-by":"publisher","first-page":"8842362","DOI":"10.1155\/2020\/8842362","article-title":"Investigation of Lipid Profile and Clinical Manifestations in SCA Children","volume":"2020","author":"\u00a0Pereira Santiago","year":"2020","journal-title":"Disease Markers"},{"key":"10.1002\/14651858.CD003427.pub5-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1469-0691.2000.tb02040.x","article-title":"Pharmacokinetics of antibiotics with special emphasis on cephalosporins","volume":"6 (Suppl 3)","author":"Craig","year":"2000","journal-title":"Clinical Microbiology and Infection"},{"issue":"6783","key":"10.1002\/14651858.CD003427.pub5-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1136\/bmj.302.6783.989","article-title":"Penicillin prophylaxis in children with sickle cell disease in Brent","volume":"302","author":"Cummins","year":"1991","journal-title":"BMJ"},{"issue":"1","key":"10.1002\/14651858.CD003427.pub5-BIB0023|cit23","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003885.pub2","article-title":"Pneumococcal vaccines for sickle cell disease (Cochrane Review)","author":"Davies","year":"2004","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD003427.pub5-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"E7","DOI":"10.1542\/peds.99.4.e7","article-title":"Nasopharyngeal carriage of penicillin resistant Streptococcus Pneumoniae in children with sickle cell disease","volume":"99","author":"Daw","year":"1997","journal-title":"Pediatrics"},{"issue":"9","key":"10.1002\/14651858.CD003427.pub5-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"e440","DOI":"10.3324\/haematol.2019.237602","article-title":"Mortality in children with sickle cell disease in mainland France from 2000 to 2015","volume":"105","author":"Desselas","year":"2020","journal-title":"Haematologica"},{"issue":"10","key":"10.1002\/14651858.CD003427.pub5-BIB0026|cit26","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1002\/ajh.24467","article-title":"Dense red blood cell and oxygen desaturation in sickle-cell disease","volume":"91","author":"Marden","year":"2016","journal-title":"American Journal of Hematology"},{"issue":"3","key":"10.1002\/14651858.CD003427.pub5-BIB0027|cit27","doi-asserted-by":"publisher","first-page":"e291","DOI":"10.1038\/nrdp.2018.10","article-title":"How many people have sickle cell disease in the UK?","volume":"40","author":"James","year":"2018","journal-title":"Journal of Public Health"},{"issue":"4","key":"10.1002\/14651858.CD003427.pub5-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1542\/peds.69.4.452","article-title":"Serum penicillin concentrations after intramuscular administration of benzathine penicillin G in children","volume":"69","author":"Ginsburg","year":"1982","journal-title":"Pediatrics"},{"issue":"7414","key":"10.1002\/14651858.CD003427.pub5-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD003427.pub5-BIB0030|cit30","unstructured":"Higgins 2011: Higgins JPT Altman DG Sterne JAC Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD003427.pub5-BIB0031|cit31","doi-asserted-by":"publisher","first-page":"18010","DOI":"10.1038\/nrdp.2018.10","article-title":"Sickle cell disease","volume":"4","author":"Kato","year":"2018","journal-title":"Nature Reviews. Disease Primers"},{"issue":"2","key":"10.1002\/14651858.CD003427.pub5-BIB0032|cit32","first-page":"177","article-title":"Compliance with intramuscular penicillin prophylaxis in children with sickle cell disease in Jamaica","volume":"60","author":"King","year":"2011","journal-title":"West Indian Medical Journal"},{"issue":"1","key":"10.1002\/14651858.CD003427.pub5-BIB0033|cit33","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001913","article-title":"Neonatal screening for sickle cell disease (Cochrane Review)","author":"Lees","year":"2000","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD003427.pub5-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1542\/peds.84.3.500","article-title":"Mortality in children and adolescents with sickle cell disease. Co-operative Study of Sickle Cell Disease","volume":"84","author":"Leikin","year":"1989","journal-title":"Pediatrics"},{"issue":"6","key":"10.1002\/14651858.CD003427.pub5-BIB0035|cit35","first-page":"543","article-title":"Clinicopathologic characteristics of septicaemia in sickle cell disease","volume":"136","author":"Lobel","year":"1982","journal-title":"American Journal of Diseases of Children"},{"issue":"3","key":"10.1002\/14651858.CD003427.pub5-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jpeds.2010.11.025","article-title":"Increase in invasive Streptococcus pneumoniae infections in children with sickle cell disease since pneumococcal conjugate vaccine licensure","volume":"158","author":"McCavit","year":"2011","journal-title":"Journal of Pediatrics"},{"issue":"2","key":"10.1002\/14651858.CD003427.pub5-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"161","DOI":"10.4161\/hv.18432","article-title":"Safety, immunogenicity and efficacy of pneumococcal conjugate vaccine in HIV-infected individuals","volume":"8","author":"Nunes","year":"2012","journal-title":"Human Vaccines & Immunotherapeutics"},{"issue":"7","key":"10.1002\/14651858.CD003427.pub5-BIB0038|cit38","first-page":"643","article-title":"Risk of Invasive Pneumococcal Disease in Children with Sickle Cell Disease in England: A National Observational Cohort Study, 2010\u20132015","volume":"103","author":"Oligbu","year":"2018","journal-title":"Archives of Disease in Childhood"},{"issue":"4","key":"10.1002\/14651858.CD003427.pub5-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/bjh.15846","article-title":"Risk of invasive pneumococcal disease in children with sickle cell disease in the era of conjugate vaccines: a systematic review of the literature","volume":"185","author":"Oligbu","year":"2019","journal-title":"British Journal of Haematology"},{"issue":"1","key":"10.1002\/14651858.CD003427.pub5-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1592\/phco.20.1.110.34660","article-title":"Duration of penicillin prophylaxis in sickle cell anemia: issues and controversies","volume":"20","author":"Pai","year":"2000","journal-title":"Pharmacotherapy"},{"issue":"23","key":"10.1002\/14651858.CD003427.pub5-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1056\/NEJM199406093302303","article-title":"Mortality in sickle cell disease: life expectancy and risk factors for early death","volume":"330","author":"Platt","year":"1994","journal-title":"New England Journal of Medicine"},{"issue":"7","key":"10.1002\/14651858.CD003427.pub5-BIB0042|cit42","doi-asserted-by":"publisher","first-page":"679\u201388","DOI":"10.1177\/1535370216640385","article-title":"Minireview: Clinical severity in sickle cell disease: the challenges of definition and prognostication","volume":"241","author":"Quinn","year":"2016","journal-title":"Experimental Biology and Medicine"},{"key":"10.1002\/14651858.CD003427.pub5-BIB0043|cit43","unstructured":"Review Manager (RevMan) The Cochrane Collaboration 2020"},{"issue":"18","key":"10.1002\/14651858.CD003427.pub5-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1056\/NEJM196605052741806","article-title":"Pneumococcal meningitis in sickle-cell anemia","volume":"274","author":"Robinson","year":"1966","journal-title":"The New England Journal of Medicine"},{"issue":"1","key":"10.1002\/14651858.CD003427.pub5-BIB0045|cit45","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.prrv.2013.11.003","article-title":"Differences in the clinical and genotypic presentation of sickle cell disease around the world","volume":"15","author":"Saraf","year":"2014","journal-title":"Paediatric Respiratory Reviews"},{"key":"10.1002\/14651858.CD003427.pub5-BIB0046|cit46","first-page":"153","volume-title":"Sickle Cell Disease","author":"Serjeant","year":"2001"},{"key":"10.1002\/14651858.CD003427.pub5-BIB0047|cit47","unstructured":"Sterne JA Egger M Moher D Chapter 10: Addressing reporting biases. In: Higgins JP, Green S (editors). Cochrane Handbook forSystematic Reviews of Interventions Version 5.1 (updated March 2011). The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"3","key":"10.1002\/14651858.CD003427.pub5-BIB0048|cit48","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1001\/archpedi.152.3.274","article-title":"Compliance with penicillin prophylaxis in patients with sickle cell disease","volume":"152","author":"Teach","year":"1998","journal-title":"Archives of Pediatrics & Adolescent Medicine"},{"issue":"10091","key":"10.1002\/14651858.CD003427.pub5-BIB0049|cit49","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/S0140-6736(17)30193-9","article-title":"Sickle cell disease","volume":"390","author":"Ware","year":"2017","journal-title":"Lancet"},{"issue":"4","key":"10.1002\/14651858.CD003427.pub5-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/00043426-199707000-00011","article-title":"Influence of penicillin prophylaxis on antimicrobial resistance in nasopharyngeal S. pneumoniae among children with sickle cell anemia. The Ancillary Nasopharyngeal Culture Study of Prophylactic Penicillin Study II","volume":"19","author":"Woods","year":"1997","journal-title":"Journal of Pediatric Hematology\/Oncology"},{"issue":"3","key":"10.1002\/14651858.CD003427.pub5-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.gheart.2013.08.011","article-title":"Benzathine Penicillin G for the Management of RHD: Concerns About Quality and Access, and Opportunities for Intervention and Improvement","volume":"8","author":"Wyber","year":"2013","journal-title":"Global Heart"},{"issue":"10","key":"10.1002\/14651858.CD003427.pub5-BIB0052|cit52","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1001\/jama.2014.10517","article-title":"Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members","volume":"312","author":"Yawn","year":"2014","journal-title":"JAMA"},{"issue":"4","key":"10.1002\/14651858.CD003427.pub5-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0022-3476(86)80216-5","article-title":"Bacteremia in sickle hemoglobinopathies","volume":"109","author":"Zarkowsky","year":"1986","journal-title":"Journal of Pediatrics"},{"issue":"3","key":"10.1002\/14651858.CD003427.pub5-BIB0054|cit54","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003427","article-title":"Prophylactic antibiotics for preventing pneumococcal infection in children with sickle cell disease","author":"Hirst","year":"2002","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"9","key":"10.1002\/14651858.CD003427.pub5-BIB0055|cit55","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003427.pub2","article-title":"Prophylactic antibiotics for preventing pneumococcal infection in children with sickle cell disease","author":"Hirst","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD003427.pub5-BIB0056|cit56","unstructured":"Prophylactic antibiotics for preventing pneumococcal infection in children with sickle cell disease Cochrane Database of Systematic Reviews 2017 10 10.1002\/14651858.CD003427.pub4"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T07:32:23Z","timestamp":1792654343000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD003427.pub5"}},"subtitle":[],"editor":[{"name":"Cochrane Cystic Fibrosis and Genetic Disorders Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,3,16]]},"references-count":56,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021,3]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd003427.pub5","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,16]]}}}